National Research Corp Stock Performance
| NRC Stock | USD 17.27 0.75 4.16% |
On a scale of 0 to 100, National Research holds a performance score of 6. The company secures a Beta (Market Risk) of -0.7, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning National Research are expected to decrease at a much lower rate. During the bear market, National Research is likely to outperform the market. Please check National Research's expected short fall, and the relationship between the value at risk and daily balance of power , to make a quick decision on whether National Research's current price movements will revert.
Risk-Adjusted Performance
Mild
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in National Research Corp are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather conflicting basic indicators, National Research exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (1.62) | Five Day Return 2.85 | Year To Date Return (1.74) | Ten Year Return 9.9 | All Time Return (15.05) |
Forward Dividend Yield 0.0306 | Payout Ratio | Forward Dividend Rate 0.52 | Dividend Date 2026-01-09 | Ex Dividend Date 2025-12-26 |
1 | Terra Innovatum Advances U.S. NRC Licensing Process with Accelerated Regulatory Submissions for SOLO Reactor | 09/22/2025 |
2 | Insider Trading | 09/29/2025 |
| National Research dividend paid on 10th of October 2025 | 10/10/2025 |
3 | ME Therapeutics Granted Licence for CD22 Nanobody Asset to Expand Next-Gen In Vivo CAR Cell Therapy Program | 10/16/2025 |
4 | NRC Net Profit Margin Drops Sharply, Undermining Bull Case for Valuation Discount | 10/28/2025 |
5 | NRC Net Profit Margin Miss Reinforces Margin Pressure Narrative | 10/29/2025 |
6 | NRC Stock Up 12 percent Despite Q3 Earnings Down YY on Rising Interest Costs | 10/31/2025 |
7 | What makes National Research Corporation stock appealing to growth investors - Quarterly Market Summary Safe Capital Growth Trade Ideas - newser.com | 11/04/2025 |
8 | Israel accused of blocking thousands of truckloads of Gaza aid month after Trumps ceasefire began | 11/06/2025 |
9 | Stage-Gate International Anchors Canadian Collaboration to Unlock Commercialization Performance and Strengthen Global Innovation Competitiveness | 11/12/2025 |
10 | What consensus target says about National Research Corporation stock - Entry Point High Conviction Buy Zone Picks - newser.com | 11/19/2025 |
11 | Bear of the Day NuScale Power | 11/24/2025 |
12 | Better Nuclear Play NuScale Power vs. Oklo | 11/26/2025 |
| Begin Period Cash Flow | 6.7 M | |
| Total Cashflows From Investing Activities | -20.3 M |
National Research Relative Risk vs. Return Landscape
If you would invest 1,494 in National Research Corp on August 31, 2025 and sell it today you would earn a total of 233.00 from holding National Research Corp or generate 15.6% return on investment over 90 days. National Research Corp is generating 0.2788% of daily returns assuming volatility of 3.1959% on return distribution over 90 days investment horizon. In other words, 28% of stocks are less volatile than National, and above 95% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
National Research Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for National Research's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as National Research Corp, and traders can use it to determine the average amount a National Research's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0872
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | NRC | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.2 actual daily | 28 72% of assets are more volatile |
Expected Return
| 0.28 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 6 94% of assets perform better |
Based on monthly moving average National Research is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of National Research by adding it to a well-diversified portfolio.
National Research Fundamentals Growth
National Stock prices reflect investors' perceptions of the future prospects and financial health of National Research, and National Research fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on National Stock performance.
| Return On Equity | 0.67 | ||||
| Return On Asset | 0.13 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | 0.22 % | ||||
| Current Valuation | 462.77 M | ||||
| Shares Outstanding | 22.66 M | ||||
| Price To Earning | 26.72 X | ||||
| Price To Book | 26.89 X | ||||
| Price To Sales | 2.82 X | ||||
| Revenue | 143.06 M | ||||
| Gross Profit | 86.32 M | ||||
| EBITDA | 41.31 M | ||||
| Net Income | 24.78 M | ||||
| Cash And Equivalents | 32.97 M | ||||
| Cash Per Share | 1.33 X | ||||
| Total Debt | 64.41 M | ||||
| Debt To Equity | 0.37 % | ||||
| Current Ratio | 1.31 X | ||||
| Book Value Per Share | 0.63 X | ||||
| Cash Flow From Operations | 34.62 M | ||||
| Earnings Per Share | 0.71 X | ||||
| Market Capitalization | 391.85 M | ||||
| Total Asset | 132.54 M | ||||
| Retained Earnings | (17.06 M) | ||||
| Working Capital | (16.26 M) | ||||
| Current Asset | 27.6 M | ||||
| Current Liabilities | 12.83 M | ||||
About National Research Performance
By analyzing National Research's fundamental ratios, stakeholders can gain valuable insights into National Research's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if National Research has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if National Research has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 31.75 | 20.22 | |
| Return On Tangible Assets | 0.39 | 0.25 | |
| Return On Capital Employed | 0.36 | 0.28 | |
| Return On Assets | 0.19 | 0.20 | |
| Return On Equity | 0.79 | 0.50 |
Things to note about National Research Corp performance evaluation
Checking the ongoing alerts about National Research for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for National Research Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| National Research had very high historical volatility over the last 90 days | |
| About 48.0% of the company outstanding shares are owned by corporate insiders | |
| On 10th of October 2025 National Research paid $ 0.12 per share dividend to its current shareholders | |
| Latest headline from techcrunch.com: Samsung Display, Chinas BOE settle OLED patent and trade secret lawsuits |
- Analyzing National Research's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether National Research's stock is overvalued or undervalued compared to its peers.
- Examining National Research's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating National Research's management team can have a significant impact on its success or failure. Reviewing the track record and experience of National Research's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of National Research's stock. These opinions can provide insight into National Research's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for National Stock analysis
When running National Research's price analysis, check to measure National Research's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National Research is operating at the current time. Most of National Research's value examination focuses on studying past and present price action to predict the probability of National Research's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National Research's price. Additionally, you may evaluate how the addition of National Research to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |